KPNA1

Across TCGA pan-cancer cohorts, KPNA1 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of KPNA1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where KPNA1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types KPNA1 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

LSCC, HNSC, and PDAC are the cancer types where KPNA1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KPNA1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Male	All	+0.499	<.001	9	view →
HNSC	All	III,IV	+0.266	<.001	8	view →
PDAC	All	All	−0.142	.015	2	view →
COAD	Female	IV	+0.360	.047	1	view →
CCRCC	All	All	+0.051	.047	1	view →
LUAD	All	All	+0.050	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

KPNA1–LSCC

Open the LSCC breakdown →